SIC score and diagnostics for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
- SIC score evaluated according to table below
- Uses prothrombin time (PT), platelet count, and sequential organ failure assessment (SOFA)
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Inclusion criteria for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
Statistical analysis for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
SIC score and diagnostics for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
SIC score and diagnostics for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China